Ingredient Dossier · 5-Brain® Formula · nutropx.com/science
Chocamine®
Standardized Cocoa Extract — Theobromine, Caffeine, and Cocoa Flavanols
Chocamine® is a patented, standardized cocoa extract from RFI LLC that delivers cocoa’s bioactive compounds — principally theobromine, caffeine, and cocoa polyphenols/flavanols — without the fat, sugar, or calories of chocolate. The 5-Brain® Chocamine® blend contains 40 mg of caffeine per daily serving and is a stimulant-containing ingredient.
Contains 40 mg caffeine per serving
Standardized to >12% theobromine
>5% cocoa polyphenols
Branded: RFI LLC (RFI Ingredients)
Self-affirmed GRAS
Chocamine®by RFI LLC
Standardized cocoa extract
>12% theobromine
>5% polyphenols
No sugar · No fat
Self-affirmed GRAS
Important: This is a stimulant-containing ingredient
40 mg
CAFFEINE PER DAILY SERVING
The 5-Brain® Chocamine® blend contains 40 mg of naturally occurring caffeine per 3-capsule daily serving — approximately half a cup of brewed coffee. The blend also contains theobromine, a related methylxanthine that acts as a milder, longer-lasting stimulant. Anyone sensitive to caffeine, pregnant, nursing, or with cardiovascular concerns should consult a healthcare provider and count this toward their daily caffeine intake from coffee, tea, energy drinks, and other sources.
FDA daily caffeine guidance
400 mg / day
Pregnancy (ACOG/EFSA)
< 200 mg / day
5-Brain® contribution
40 mg (10% of FDA limit)
5-Brain® Chocamine® blend composition
Total blend per daily serving
500 mg
Cocoa low-fat powder extract
Primary base
Theobromine (added)
In blend (exact amount not separately disclosed)
Caffeine
40 mg
Cocoa polyphenols / flavanols
>5% of cocoa extract fraction
Natural vanilla flavor, tapioca starch, spices (ginger, allspice, cinnamon)
Carrier & flavor
Theobromine isolated
1841
Woskresensky from cacao beans
5-Brain® blend
500 mg
Per 3-capsule daily serving
Theobromine half-life
~7 hr
vs caffeine ~3–6 hr
Cocoa flavanol research
2006–present
Component-level cognition studies
01
What is it?
Cocoa (Theobroma cacao) was used as a medicinal beverage by the Olmec, Maya, and Aztec from at least 1900 BCE. Its bioactive compound theobromine was chemically isolated by Woskresensky in 1841, and modern research on cocoa’s cognitive and cardiovascular bioactives has accelerated since the early 2000s.
Chocamine® is a proprietary cocoa extract from RFI LLC (formerly RFI Ingredients) standardized to deliver three classes of cocoa bioactives concentrated together without the fat, sugar, or calories of chocolate:
Methylxanthines — principally theobromine (standardized to >12% by weight in the base extract), with naturally occurring trace caffeine. The 5-Brain® blend adds caffeine to bring the total to 40 mg per daily serving. Cocoa flavanols/polyphenols — epicatechin, catechin, and procyanidins (>5% of the cocoa extract fraction). Carrier and flavor components — tapioca starch and natural spices.
Important transparency note
No peer-reviewed human clinical trial of Chocamine® specifically has been published. A direct PubMed search returns no indexed trial. Cognitive performance figures sometimes cited in marketing literature trace to unpublished, company-sponsored work (a 2009 n=40 study using the IMPACT cognitive test, and an earlier n=3 preliminary study). These have not been peer-reviewed and are not cited as evidence on this page. The published research described below is for Chocamine’s individual components: theobromine, caffeine, and cocoa flavanols. We are explicit about this throughout.
02
Research timeline
~1900 BCE
Earliest documented cocoa use — The Olmec, Maya, and Aztec civilizations prepare cocoa as a medicinal and ceremonial beverage. Recognized as a stimulating substance long before its bioactive compounds were chemically identified.
1841
Theobromine isolated — Russian chemist Alexander Woskresensky isolates theobromine from cacao beans, identifying the methylxanthine that distinguishes cocoa from coffee’s caffeine-dominant pharmacology.
Early 1900s
Theobromine pharmacology characterized — Researchers establish theobromine as a vasodilator, mild diuretic, and CNS stimulant. The longer half-life of theobromine vs caffeine is documented in early pharmacokinetic studies.
2006–2008
Cocoa flavanol cognition research begins — Schroeter et al. demonstrate epicatechin’s vascular effects (PNAS 2006). Sorond et al. (2008) report improved cerebral blood flow with cocoa flavanols. This launches the modern cocoa-flavanol cognitive research era.
2010
Scholey et al. (J Psychopharmacol) — First report of acute cognitive improvements following cocoa flavanols in healthy adults during sustained mental effort. Used a cocoa flavanol drink at 520 and 994 mg flavanols, not Chocamine®.
2011–2013
Methylxanthine-specific RCTs — Mitchell et al. (2011) and Judelson et al. (2013) directly compare isolated theobromine to caffeine. Findings: theobromine’s standalone CNS effects are modest to null; caffeine drives the alertness lift. Baggott et al. (2013) confirm theobromine has dose-dependent effects, with negative mood effects at higher doses.
2014–2015
Cocoa flavanols, brain blood flow, and cognition — Brickman et al. (Nature Neuroscience 2014) demonstrate cocoa flavanols can enhance dentate gyrus function in older adults. Mastroiacovo et al. (CoCoA Study 2015) shows 8-week flavanol intake associated with cognitive measures in elderly. All used cocoa-flavanol drinks, not Chocamine®.
2024
Akyürek et al. (Eur J Nutr) — recent null finding — Cocoa flavanols (415 mg) plus caffeine (200 mg) did NOT acutely modulate working memory or attention in a well-controlled study — an important balance counterweight to the positive flavanol literature.
03
How it works — mechanisms of action
Chocamine®’s plausible brain mechanisms operate through three families of compounds. These are studied mechanisms at the component level — mechanism characterization does not by itself prove efficacy at the 5-Brain® serving size.
Chocamine® bioactives — methylxanthines and cocoa flavanols
Chocamine® delivers three bioactive families. Caffeine has the strongest acute effect on alertness; theobromine has gentler and longer-lasting effects but modest standalone cognitive results; cocoa flavanol effects on cognition depend on dose levels that we cannot confirm Chocamine delivers at the 500 mg serving.
Caffeine (acute stimulant)
Other cocoa bioactives
Chocamine® extract
Professor 5-Brain explains
Think of Chocamine as bringing three different things to the cocoa experience. Caffeine is the quick spark — it blocks the “you’re tired” signal in your brain by sitting on adenosine receptors. Theobromine is its mellower cousin — same family, longer lasting, gentler effect. And cocoa flavanols are studied for supporting healthy blood flow to brain tissue. The honest part: research suggests caffeine drives most of the immediate alertness, theobromine’s solo cognitive effects are modest, and the flavanol cognition story depends on doses we can’t confirm 5-Brain delivers.
Methylxanthines & adenosine receptors
Both caffeine and theobromine are methylxanthines that cross the blood-brain barrier and act as adenosine receptor antagonists, reducing the fatigue signal and promoting alertness. Caffeine is the stronger, faster-acting CNS stimulant; theobromine is milder and longer-acting (half-life ~7 hours vs caffeine’s ~3–6 hours).
Well-established pharmacology
Cocoa flavanols & cerebral blood flow
Cocoa flavanols (chiefly epicatechin) are studied for stimulation of endothelial nitric oxide synthase (eNOS), associated with vasodilation including in cerebral vessels. Brickman 2014 reported increased dentate gyrus cerebral blood volume with cocoa flavanols. The proposed route by which flavanols may support cognitive function.
Mechanism evidence — cocoa flavanol component, not Chocamine-specific
Dopamine & monoamine modulation
Cocoa methylxanthines and flavanols are studied for associations with monoaminergic neurotransmission. Mechanism rationale for cocoa’s traditional association with mood and motivation — framed conservatively at the mechanism level.
Mechanism context · Not a therapeutic claim
Polyphenol antioxidant activity
Cocoa polyphenols are studied as antioxidants relevant to cellular oxidative stress. General supporting mechanism context; the antioxidant story is well-established for cocoa polyphenols as a class.
Established mechanism
BDNF (preclinical only)
Preclinical research suggests cocoa flavanols (and theobromine in animal models) may modulate BDNF (brain-derived neurotrophic factor) and VEGF signaling. Animal-model evidence only — no human BDNF data for Chocamine® or cocoa flavanols at supplement doses.
Animal research only
Theobromine’s longer half-life
Theobromine’s longer elimination half-life (~7 hours) compared to caffeine (~3–6 hours) is the mechanistic basis for the “smoother, more sustained” cocoa profile. This is the strongest theobromine-specific differentiator from pure caffeine.
Established pharmacokinetics
A note on phenylethylamine (PEA): Cocoa contains small amounts of PEA, sometimes called the “love molecule” in popular literature. Orally ingested PEA is very rapidly metabolized by monoamine oxidase-B (half-life of minutes), so little reaches the brain. PEA is not a meaningful active mood mechanism for an oral supplement and is not claimed as one here.
04
5-Brain® system mapping
Chocamine®’s 5-Brain® associations are anchored in well-characterized component-level mechanisms (methylxanthines and cocoa flavanols). The 40 mg caffeine is the most reliable acute alertness driver in the blend.
Focus & Attention
Primary domain. Caffeine is one of the most extensively studied compounds for acute alertness and attention. The 40 mg dose is the most reliable acute alertness driver in the 5-Brain® formula.
Brain Energy & Longevity
Methylxanthines (caffeine + theobromine) reduce the adenosine fatigue signal. Cocoa polyphenols studied for antioxidant activity relevant to cellular oxidative defense.
Mood & Stress Resilience
Caffeine reliably reported for acute mood elevation in trials. Cocoa flavanols and methylxanthines studied for associations with monoaminergic pathways. Mechanism-level association only.
Memory & Learning
Cocoa flavanols studied for memory-related outcomes in research, but flavanol doses in 5-Brain® cannot be confirmed to match study doses. Mechanism rationale only.
Neural Communication
Indirect via methylxanthine and flavanol pathways. Not a primary studied domain.
05
Research evidence — component level
None of the studies below used Chocamine®. They tested isolated theobromine, caffeine, theobromine+caffeine combinations, cocoa-flavanol drinks, or dark chocolate. Each citation states the form tested. The published research supports the underlying mechanisms but cannot be cited as “Chocamine® was shown to…” outcomes.
Baggott et al. (2013) — Psychopharmacology
n=80 healthy adults · Oral theobromine at 250, 500, 1,000 mg vs caffeine 200 mg vs placebo · Single-dose acute
Caffeine produced expected increases in alertness and cardiovascular parameters. Theobromine showed only limited subjective effects at 250 mg and negative mood effects with dose-dependent heart-rate increases at 500 and 1,000 mg. Authors concluded theobromine at normal dietary intake ranges may contribute to chocolate’s positive effects, but at higher intakes effects become negative. An important balance finding showing more theobromine is not better.
Key takeawayCocoa flavanol study at higher flavanol doses than Chocamine® delivers. Reported associations with cerebral blood flow measures in healthy adults. Used a different cocoa product; provides category-level mechanism support, not Chocamine-specific.
Mitchell et al. (2011) — Physiology & Behavior
n=24 healthy females · Theobromine 700 mg, caffeine 120 mg, combination, or placebo · Acute
Caffeine reliably increased self-reported alertness and contentedness, and raised blood pressure. Theobromine alone decreased calmness at 3 hours and lowered blood pressure. The combination behaved like caffeine on mood but with no net effect on blood pressure. No treatment effect on the Digit Symbol Substitution Test cognitive measure. Provides direct evidence that caffeine drives the alertness lift and theobromine’s standalone CNS effects are limited.
Key takeawayTheobromine standalone study at higher doses than Chocamine® provides. Effects on cognition were modest. Suggests theobromine’s solo cognitive contribution is real but limited.
Judelson et al. (2013) — J Clinical Psychopharmacology
n=24 healthy males · Theobromine 100, 200, 400 mg in cocoa beverage vs caffeine 100 mg · Acute · Industry-funded (Hershey)
Theobromine at nutritionally relevant doses did NOT influence mood or vigilance, despite crossing the blood-brain barrier and binding adenosine receptors. Caffeine (positive control) had the expected effects. Important counter-evidence showing theobromine alone, at realistic dietary doses, may not produce alertness or mood lift — supports framing caffeine as the alertness driver, not theobromine.
Key takeawayAcute cocoa polyphenol study reporting associations with cognitive measures and mental fatigue. Used a different cocoa product; supports the category-level mechanism but not Chocamine® specifically.
Scholey et al. (2010) — J Psychopharmacology
n=30 healthy adults · Cocoa flavanols 520 or 994 mg vs control · Acute · ~1 hr Cognitive Demand Battery
Researchers reported associations with cognitive performance during sustained mental effort and reduced self-reported mental fatigue. Both doses produced associations with serial-subtraction speed and accuracy. First report of acute cognitive associations with cocoa flavanols in healthy adults. Mechanisms posited to relate to flavanol effects on cerebral blood flow.
Key takeawayCaffeine acute effects in well-rested adults. Confirms the well-known caffeine alertness mechanism — relevant because Chocamine® delivers 40 mg of caffeine per daily serving.
Field et al. (2011) — Physiology & Behavior
n=30 healthy young adults · Dark chocolate ~720 mg flavanols vs white chocolate · Acute, ~2 hr post-consumption
Dark chocolate associated with visual contrast sensitivity, motion-direction detection, spatial working memory, and choice reaction time vs white chocolate. Important limitation: not double-blind (dark vs white chocolate are distinguishable), and dark contained caffeine and theobromine while white did not — so attribution to flavanols specifically is not clean.
Key takeawayCocoa flavanols and cerebral blood flow at higher doses. Supports the flavanol mechanism narrative but at doses 5-Brain® likely cannot match through Chocamine alone.
Mastroiacovo et al. (2015) — Am J Clin Nutr · CoCoA Study
n=90 cognitively intact elderly · 48, 520, or 993 mg cocoa flavanols/day · 8 weeks · Industry-funded (Mars)
Intermediate and high flavanol groups associated with attention/executive function and verbal memory measures vs low group. Cognitive associations were possibly mediated by improved insulin sensitivity. Population: elderly. Doses: 520–993 mg flavanols — we cannot confirm 5-Brain® delivers this flavanol dose. Strongest evidence that flavanols, not just caffeine, contribute to the cocoa-cognition story.
Key takeawayCocoa flavanol study in healthy older adults reporting cognitive measure associations. Used a different cocoa product at flavanol doses higher than Chocamine® delivers.
Brickman et al. (2014) — Nature Neuroscience
Healthy adults 50–69 · High vs low cocoa flavanol diet · 3 months · High-resolution fMRI
High-flavanol diet associated with increased cerebral blood volume in the dentate gyrus (a hippocampal region tied to age-related memory) and associations with hippocampus-dependent recognition task performance. Provides causal human mechanism evidence linking flavanols → dentate gyrus → memory in older adults. Population: older adults; mechanism context for 5-Brain® rather than dose-equivalent.
Key takeawayCocoa polyphenol intervention reporting cognitive associations. Category-level evidence; not Chocamine® specifically.
Akyürek, Altınok & Karabay (2024) — European Journal of Nutrition
Acute trial · Cocoa flavanols 415 mg + caffeine 200 mg · Working memory & attention
A well-controlled recent study found that cocoa flavanols (415 mg) combined with caffeine (200 mg) did NOT acutely modulate working memory or attention performance. An important balance finding cited transparently here as evidence that the flavanol cognition story is not uniformly positive even in acute trials.
Key takeawayRecent Akyurek et al. 2024 trial — the closest available study to Chocamine® methodology. Reported null findings on cognitive endpoints. The most honest counterweight in the cocoa literature.
Socci et al. (2017) — Frontiers in Nutrition
Review of cocoa-flavanol human cognition studies (acute + chronic)
Across the cocoa flavanol literature, researchers summarized dose-dependent associations with attention, processing speed, and working memory; mechanisms proposed include cerebral blood flow, BDNF (preclinical), and neuronal efficiency. Useful for mechanism narrative; review-level evidence is supporting context, not primary.
Key takeawayCocoa flavanol meta-analysis pooling multiple studies. Effects were modest and heterogeneous across studies. Category-level evidence; not Chocamine® specific.
06
What the research actually says
Honest evidence summary
Chocamine® is the most evidence-nuanced ingredient in the 5-Brain® formula, and warrants the most careful framing. The picture below is honest about both the well-supported caffeine mechanism and the limits of the broader cocoa cognition story.
What studies consistently support
- Caffeine’s acute alertness mechanism is among the most well-established findings in cognitive pharmacology. Chocamine® delivers 40 mg of caffeine per daily serving — the most reliable acute driver in the blend.
- Cocoa flavanols have been associated with cerebral blood flow in human studies via endothelial nitric-oxide pathways (Francis 2006 and others) — established mechanism direction.
- Acute cocoa flavanol intake has been associated with cognitive performance during sustained mental effort in healthy adults (Scholey 2010 and others), at higher flavanol doses than 5-Brain® delivers.
- Methylxanthine pharmacology (adenosine receptor antagonism by caffeine and theobromine) is well-characterized at the textbook biochemistry level.
What remains uncertain
- No peer-reviewed clinical trial of Chocamine® specifically has been published. The performance figures sometimes cited in cocoa marketing trace to unpublished company-sponsored work that has not been peer-reviewed.
- Whether 5-Brain®’s Chocamine® serving delivers flavanols at doses comparable to positive cognitive trials (typically 520–994 mg of flavanols). The flavanol content within Chocamine® has not been independently characterized.
- Theobromine’s standalone cognitive effects are modest to null at realistic supplement doses. Mitchell 2011 and Judelson 2013 found theobromine alone did not improve cognitive performance.
- The Akyürek 2024 trial was null on cognitive measures even with 415 mg flavanols plus 200 mg caffeine — the most recent honest counterweight to the cocoa-cognition narrative.
What to realistically expect
- The 40 mg of caffeine is the most direct acute mechanism. Treat Chocamine® as the acute-acting ingredient in the formula, complementing the chronic-dosing ingredients (Bacopa, ALCAR).
- Expect the caffeine effect: moderate alertness, attention support. Not stimulant intensity at 40 mg.
- Theobromine and cocoa flavanols contribute supporting mechanism context, not standalone outcome claims at this serving.
- 40 mg caffeine matters — about half the caffeine of an 8-oz cup of coffee. Plan your daily intake accordingly, especially if combining with coffee or other caffeine sources.
Professor 5-Brain — the honest take
Chocamine® is where the supplement industry usually overclaims, and we’ve worked to do the opposite. We’re not telling you cocoa flavanols make you smarter at our dose — the flavanol content isn’t characterized, the positive studies used much higher doses, and the most recent trial (Akyürek 2024) was null. What we will tell you: 5-Brain® has 40 mg of caffeine from Chocamine®, which is the most reliable acute mechanism in the blend, plus a standardized cocoa-spectrum context. Treat it as gentle caffeine + a cocoa background, not as a flavanol cognition booster.
07
Why we selected Chocamine®
Formulation rationale
Concentrated cocoa actives without chocolate’s baggage. Chocamine® delivers theobromine, caffeine, and cocoa polyphenols in a standardized extract — no sugar, fat, dairy, or calories. For a daily brain supplement, this is meaningfully different from chocolate as a delivery vehicle.
The theobromine differentiator. Theobromine’s longer half-life (~7 hours vs caffeine’s ~3–6) is the mechanistic basis for cocoa’s smoother, more sustained energy profile compared to pure caffeine sources. This is the strongest theobromine-specific differentiator and the reason cocoa extracts are preferred over isolated caffeine for some users.
Moderate, transparent caffeine dose. The 40 mg caffeine is intentionally moderate — approximately half a cup of brewed coffee, 10% of the FDA’s 400 mg daily guidance for adults. It is the most reliable acute alertness driver in the formula while staying well within sensible daily limits, even when combined with normal coffee or tea consumption.
Complementary timescale within the formula. Where Bacopa monnieri, ALCAR, and Sharp-PS® Green operate on longer-term mechanisms (synaptic, mitochondrial, structural), Chocamine® provides a near-term alertness and focus mechanism. This timescale contrast is intentional — immediate signal alongside long-term support.
08
Synergy within the 5-Brain® formula
Chocamine® + ALCAR
Chocamine® provides near-term methylxanthine alertness; ALCAR contributes to underlying mitochondrial energy metabolism. Acute signal plus cellular energy substrate — different timescales within the same energy-support dimension.
Acute alertness + cellular energy
Chocamine® + Ginkgo
Cocoa flavanols are studied for cerebral blood flow associations; Ginkgo is studied for cerebrovascular mechanisms. Both ingredients have studied associations with vascular pathways relevant to brain function.
Complementary vascular mechanisms
Chocamine® + Bacopa
Chocamine® contributes near-term focus and alertness via caffeine; Bacopa is studied for cumulative memory-related cognitive support over weeks. Near-term and long-term cognitive dimensions in one formula.
Immediate + long-term
Chocamine® + Meriva®
Cocoa polyphenols and curcuminoids are both studied for antioxidant mechanisms. Two distinct polyphenol classes contributing to oxidative defense through different molecular targets.
Dual polyphenol antioxidant
09
Dosage & timing
5-Brain® dose
500 mg
Chocamine® blend per day · contains 40 mg caffeine
Take in the morning — the 40 mg caffeine and longer-acting theobromine can affect sleep latency if taken late in the day; avoid afternoon and evening dosing
Count toward your daily caffeine intake from coffee, tea, energy drinks, pre-workout supplements, and chocolate
Cocoa flavanol research used 520–994 mg of flavanols — the 5-Brain® Chocamine® blend has not been characterized for its exact flavanol content; dose-equivalence claims cannot be supported
Discontinue at least 2 weeks before scheduled surgery — stimulant content and anesthesia considerations
10
Safety & tolerability
Caffeine sensitivity, pregnancy, and stacking matter: 5-Brain®’s 40 mg caffeine per daily serving is moderate but not negligible. Pregnant or nursing women should limit caffeine to under 200 mg/day from all sources (ACOG, EFSA) and consult their healthcare provider before use. Anyone with caffeine sensitivity, arrhythmia, hypertension, anxiety conditions, or who takes stimulant medications should consult a provider. Add the 40 mg to your total daily caffeine count from coffee, tea, energy drinks, and chocolate.
Established tolerability
- 40 mg caffeine is well within the FDA’s 400 mg/day guidance for healthy adults (10% of limit)
- Cocoa powder is GRAS; theobromine has GRAS determination (GRN 340)
- Chocamine® is marketed as self-affirmed GRAS by RFI LLC
- Theobromine well-tolerated at dietary levels in published research
- Mild GI effects (transient nausea) possible in caffeine-sensitive users
Important cautions
- Pregnancy & nursing: limit total caffeine to < 200 mg/day from all sources; consult provider
- Arrhythmia, hypertension, cardiovascular conditions: consult healthcare provider before use
- Anxiety conditions or caffeine sensitivity: caffeine can amplify symptoms; consult provider
- Stimulant medications, MAOIs, CYP1A2-affecting drugs: consult provider for possible interactions
- Avoid late-day dosing — can affect sleep onset (theobromine half-life ~7 hr; caffeine ~3–6 hr)
- Keep away from dogs and cats — theobromine is toxic to pets, which metabolize it far more slowly than humans
- Discontinue at least 2 weeks before scheduled surgery
11
Frequently asked questions
How much caffeine is in 5-Brain®?
The 5-Brain® Chocamine® blend contains 40 mg of caffeine per 3-capsule daily serving — approximately half a cup of brewed coffee. The blend also contains theobromine, a related methylxanthine with a longer half-life and milder stimulant effect than caffeine. If you regularly drink coffee, tea, or energy drinks, include the 40 mg in your daily total. The FDA’s guidance for healthy adults is up to 400 mg/day; for pregnancy, ACOG and EFSA both advise under 200 mg/day.
Has Chocamine® itself been studied in clinical trials?
No peer-reviewed clinical trial of Chocamine® specifically has been published. A PubMed search for Chocamine returns no indexed clinical trial. The performance figures sometimes seen in marketing literature trace to unpublished, company-sponsored studies that have not undergone peer review. We do not cite those numbers as evidence. The published research on this page is for Chocamine’s individual components — theobromine, caffeine, and cocoa flavanols — which establishes the underlying mechanisms.
What is theobromine and how is it different from caffeine?
Theobromine is the principal methylxanthine in cocoa — chemically related to caffeine but pharmacologically milder. Both compounds work by blocking adenosine receptors in the brain, reducing the fatigue signal. Theobromine has a longer half-life (~7 hours vs caffeine’s ~3–6 hours), which is the mechanistic basis for cocoa’s “smoother, longer-lasting” energy profile compared to coffee. However, direct-comparison studies (Mitchell 2011, Judelson 2013) show theobromine alone has limited acute CNS effects — caffeine is the main driver of the alertness lift in cocoa-based ingredients.
Can I take 5-Brain® if I’m sensitive to caffeine?
If you are sensitive to caffeine, take the 40 mg caffeine content seriously when deciding whether 5-Brain® is appropriate for you. Some caffeine-sensitive individuals tolerate 40 mg well, particularly in the morning; others find any amount disruptive. Consider taking it earlier in the day, with food, and consult your healthcare provider if you have anxiety conditions, arrhythmia, or other caffeine-sensitive concerns. The Chocamine® blend is not a caffeine-free or stimulant-free ingredient.
Why include caffeine in a brain supplement at all?
Caffeine is one of the most rigorously studied compounds in human pharmacology for acute alertness, attention, and reaction time. In the 5-Brain® formula, the 40 mg dose serves as the near-term, immediate-effect ingredient — complementary to the longer-term mechanisms of Bacopa, ALCAR, and Sharp-PS®. We chose to deliver caffeine through Chocamine® rather than as isolated caffeine because cocoa also provides theobromine (longer-lasting, milder profile) and polyphenols (antioxidant mechanism). The trade-off is that anyone monitoring caffeine intake needs to count the 40 mg toward their daily total.
References
Baggott MJ et al. (2013) Psychopharmacology 228(1):109–18 · PMID 23420115 · Mitchell ES et al. (2011) Physiol Behav 104(5):816–22 · PMID 21839757 · Judelson DA et al. (2013) J Clin Psychopharmacol 33(4):499–506 · PMID 23764688 · Scholey AB et al. (2010) J Psychopharmacol 24(10):1505–14 · PMID 18684746 · Field DT et al. (2011) Physiol Behav 103(3-4):255–60 · PMID 21324330 · Mastroiacovo D et al. (2015) Am J Clin Nutr 101(3):538–48 · PMID 25733639 · Brickman AM et al. (2014) Nat Neurosci 17(12):1798–803 · PMID 25344629 · Akyürek E et al. (2024) Eur J Nutr · DOI 10.1007/s00394-024-03514-8 · Socci V et al. (2017) Front Nutr 4:19 · PMID 28560212
Baggott MJ et al. (2013) Psychopharmacology 228(1):109–18 · PMID 23420115 · Mitchell ES et al. (2011) Physiol Behav 104(5):816–22 · PMID 21839757 · Judelson DA et al. (2013) J Clin Psychopharmacol 33(4):499–506 · PMID 23764688 · Scholey AB et al. (2010) J Psychopharmacol 24(10):1505–14 · PMID 18684746 · Field DT et al. (2011) Physiol Behav 103(3-4):255–60 · PMID 21324330 · Mastroiacovo D et al. (2015) Am J Clin Nutr 101(3):538–48 · PMID 25733639 · Brickman AM et al. (2014) Nat Neurosci 17(12):1798–803 · PMID 25344629 · Akyürek E et al. (2024) Eur J Nutr · DOI 10.1007/s00394-024-03514-8 · Socci V et al. (2017) Front Nutr 4:19 · PMID 28560212
This page is for educational and informational purposes only. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This product contains 40 mg of caffeine per daily serving. Consult your healthcare provider before beginning any supplement regimen, particularly if you are pregnant, nursing, sensitive to caffeine, take stimulant medications, have a cardiovascular condition, arrhythmia, anxiety condition, or take MAOI or CYP1A2-affecting medications. Discontinue use at least 2 weeks before surgery. Keep out of reach of pets — theobromine is toxic to dogs and cats.